Paradigm Medivision Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 3.08 Cr
as on 22-06-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.04 Cr
as on 22-06-2024
- Satisfied Charges ₹ 10.18 Cr
as on 22-06-2024
- Revenue -20.56%
(FY 2019)
- Profit -80.96%
(FY 2019)
- Ebitda -6.96%
(FY 2019)
- Net Worth 0.55%
(FY 2019)
- Total Assets -23.54%
(FY 2019)
About Paradigm Medivision
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.08 Cr.
The company currently has active open charges totaling ₹2.04 Cr. The company has closed loans amounting to ₹10.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vedprakash Vyas and Jyothi Vyas serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC043554
- Company No.
043554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2004
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Paradigm Medivision?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vedprakash Vyas  | Additional Director | 01-Apr-2013 | Current |
| Jyothi Vyas | Additional Director | 01-Apr-2021 | Current |
Financial Performance of Paradigm Medivision.
Paradigm Medivision Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 20.56% decrease. The company also saw a substantial fall in profitability, with a 80.96% decrease in profit. The company's net worth moved up by a moderate rise of 0.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paradigm Medivision?
In 2019, Paradigm Medivision had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Totus Health Care (India) LimitedActive 30 years 7 monthsVedprakash Vyas and Jyothi Vyas are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 06 Oct 2016 | ₹0.43 M | Open |
Syndicate Bank Creation Date: 13 Apr 2016 | ₹2.00 Cr | Open |
Reliance Capital Ltd Creation Date: 30 Nov 2010 | ₹3.68 M | Satisfied |
How Many Employees Work at Paradigm Medivision?
Unlock and access historical data on people associated with Paradigm Medivision, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paradigm Medivision, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paradigm Medivision's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
